Capotiazide (captopril) tablets №20

$8.00

Manufacturer: Ukraine

Purpose: Inhibits angiotensin-converting enzyme for hypertension and heart failure treatment.

SKU: MED56819 Category:

Description

Capotiazide (Captopril) Tablets

Ingredients:

Each tablet contains captopril as the active ingredient.

Mechanism of Action:

Captopril acts as an angiotensin-converting enzyme (ACE) inhibitor, leading to vasodilation and reduced aldosterone secretion, ultimately resulting in decreased blood pressure levels.

Pharmacological Properties:

The pharmacological properties of captopril include its ability to inhibit ACE, thereby modulating the renin-angiotensin-aldosterone system and promoting vasodilation.

Indications for Use:

Capotiazide tablets are indicated for the treatment of hypertension in patients requiring ACE inhibitor therapy.

Contraindications:

Avoid using Capotiazide tablets if pregnant, have a history of angioedema related to previous ACE inhibitor therapy, or severe renal impairment is present.

Side Effects:

Common side effects may include hypotension, hyperkalemia, cough, and dizziness. Contact a healthcare provider if any adverse reactions occur.

Usage Instructions:

Take one tablet daily with a glass of water at the same time each day, as directed by a healthcare provider.

Benefits Compared to Analogues:

Capotiazide tablets offer effective blood pressure control with a well-established safety profile compared to other ACE inhibitors.

Suitable Patient Groups:

Capotiazide tablets are suitable for adult patients with hypertension. Consult a healthcare provider for dosing adjustments in specific populations such as children or the elderly.

Storage and Shelf Life:

Store Capotiazide tablets in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use if expired.

Packaging Description:

The product comes in a package containing 20 tablets of captopril, each labeled with dosage information and expiration date.

Clinical Evidence and Proven Effectiveness:

Capotiazide tablets have undergone rigorous clinical trials demonstrating their efficacy in reducing blood pressure levels and improving cardiovascular outcomes in patients with hypertension.